April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Feasibility Study on Intravitreal and Subretinal Delivery of Adult Stem/Progenitor Cells (MSCs) for Retinal Repair
Author Affiliations & Notes
  • R. H. Rosa, Jr.
    Dept of Ophthalmology, Scott & White Eye Institute, Temple, Texas
  • G. W. Roddy
    Institute for Regenerative Medicine, Texas A&M Health Science Center, Temple, Texas
  • U. C. Krause
    Institute for Regenerative Medicine, Texas A&M Health Science Center, Temple, Texas
  • D. J. Prockop
    Institute for Regenerative Medicine, Texas A&M Health Science Center, Temple, Texas
  • Footnotes
    Commercial Relationships  R.H. Rosa, Jr., None; G.W. Roddy, None; U.C. Krause, None; D.J. Prockop, None.
  • Footnotes
    Support  NIH Grant K08EY016143 (RHR), NCRR/NIH Grant P40 RR 17447 (DJP), Scott & White Research Grants Program (RHR, DJP), Texas A&M Health Science Center (GWR)
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 3153. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R. H. Rosa, Jr., G. W. Roddy, U. C. Krause, D. J. Prockop; Feasibility Study on Intravitreal and Subretinal Delivery of Adult Stem/Progenitor Cells (MSCs) for Retinal Repair. Invest. Ophthalmol. Vis. Sci. 2010;51(13):3153.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : The current understanding of mesenchymal stem cell (MSC) biology indicates that MSCs are able to secrete anti-apoptotic, pro-growth, and/or anti-inflammatory proteins depending on the specific need of the injured tissue in order to preserve function. A limited number of in vivo studies with MSCs suggest a positive effect on the rescue of retinal degeneration. The mechanism of rescue effect, however, is not clearly established based on the published studies. We wish to determine the mechanism(s) by which photoreceptors and/or RPE are rescued by MSCs. Herein, we evaluated the feasibility of intravitreal and subretinal injections of MSCs in rodent and porcine experimental models.

Methods: : After IACUC approval, adult Long Evans rats were sedated with a ketamine cocktail and redosed as needed and pigs (10-12 weeks old) were anesthetized with isoflurane for the entire length of the procedure. Pupil-dilating drops (tropicamide 0.5-1%, phenylephrine 2.5%) were paced in both eyes. Retinal fundus photography was performed with the RetCam II before and after the injections. Intravitreal injection of GFP-labeled mouse MSCs (10 µl/200,000 cells/PBS in rats; 50µl/1,000,000 cells/PBS in pigs; 30 gauge needle) was performed in the right eye followed by subretinal injection of mouse mesenchymal stem cells (2µl/40,000 cells/PBS in rats; 10µl/200,000 cells/PBS in pigs; 30 gauge needle) in the left eye using an operating microscope. The eyes were enucleated, and the animal subjects were euthanized. The eyes were examined by light and fluorescence microscopy.

Results: : Retinal fundus photography and histologic studies demonstrated the delivery of MSCs into the vitreous cavity and subretinal space in both rat and pig eyes. Intravitreal injections were performed without complications in both species. Acute complications with subretinal injections in both species included vitreous and subretinal hemorrhage and retinal perforation.

Conclusions: : Intravitreal and subretinal delivery of MSCs is technically feasible in both small and large animal models. Potential complications with subretinal injections include intraocular hemorrhage and retinal perforation. Future studies will evaluate the potential benefit of high resolution ultrasound-guided microinjections of MSCs into the subretinal space and the mechanism(s) of rescue of retinal degeneration by MSCs.

Keywords: immunomodulation/immunoregulation • neuroprotection • retina 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×